1. Home
  2. CCS vs HRMY Comparison

CCS vs HRMY Comparison

Compare CCS & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

HOLD

Current Price

$69.12

Market Cap

1.7B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$34.59

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCS
HRMY
Founded
2000
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
CCS
HRMY
Price
$69.12
$34.59
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$64.80
$44.11
AVG Volume (30 Days)
334.7K
756.0K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
7.97
EPS
0.84
0.55
Revenue
$4,117,816,000.00
$868,453,000.00
Revenue This Year
N/A
$19.75
Revenue Next Year
$10.84
$12.88
P/E Ratio
$74.74
$62.11
Revenue Growth
N/A
21.51
52 Week Low
$47.28
$25.52
52 Week High
$76.00
$40.87

Technical Indicators

Market Signals
Indicator
CCS
HRMY
Relative Strength Index (RSI) 76.37 61.21
Support Level $55.64 $25.92
Resistance Level $70.86 $35.47
Average True Range (ATR) 2.58 1.05
MACD 1.06 -0.01
Stochastic Oscillator 90.58 64.81

Price Performance

Historical Comparison
CCS
HRMY

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: